Company: CVS Health Corporation
Ticker: CVS
Form: 10-K
Filed: 2026-02-10
Fiscal Period: {"fp": "FY", "fy": 2025}

Question: What was CVS Health Corporation's operating cash flow in fiscal year 2025?
Question Type: value_lookup

Concept: NetCashProvidedByUsedInOperatingActivities
Answer (Numeric): 10639.0
Answer (Display): $10,639 million
Unit: USD millions

Evidence:
[{"chunk_id": "269", "equivalent_chunk_ids": ["269"], "section": "Consolidated Statements of Cash Flows", "supports": ["main"], "text": "For the Years Ended December 31,\nIn millions\nCash flows from operating activities:\nCash receipts from customers\n389,128\n357,995\n345,464\nCash paid for inventory, prescriptions dispensed and health services rendered\n216,493\n197,726\n208,848\nInsurance benefits paid\n121,238\n109,464\n84,097\nCash paid to other suppliers and employees\n37,570\n38,821\n34,735\nInterest and investment income received\n1,969\n1,735\n1,584\nInterest paid\n2,991\n2,909\n2,418\nIncome taxes paid\n2,166\n1,703\n3,524\nNet cash provided by operating activities\n10,639\n9,107\n13,426\nCash flows from investing activities:\nProceeds from sales and maturities of investments\n12,383\n10,353\n7,729\nPurchases of investments\n15,012\n15,191\n9,043\nPurchases of property and equipment\n2,832\n2,781\n3,031\nAcquisitions (net of cash and restricted cash acquired)\n16,612\nOther\nNet cash used in investing activities\n5,871\n7,613\n20,889\nCash flows from financing activities:\nCommercial paper borrowings (repayments), net\n2,119\n1,919\nProceeds from issuance of short-term loan\n5,000\nRepayment of short-term loan\n5,000\nProceeds from issuance of long-term debt\n3,969\n7,913\n10,898\nRepayments of long-term debt\n3,629\n4,773\n3,166\nRepurchase of common stock\n3,023\n2,012\nDividends paid\n3,397\n3,373\n3,132\nProceeds from exercise of stock options\nPayments for taxes related to net share settlement of equity awards\nOther\nNet cash provided by (used in) financing activities\n4,940\n1,135\n2,683\nNet increase (decrease) in cash, cash equivalents and restricted cash\n4,780\nCash, cash equivalents and restricted cash at the beginning of the period\n8,884\n8,525\n13,305\nCash, cash equivalents and restricted cash at the end of the period\n8,712\n8,884\n8,525"}]

Derivation: